Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol NR1I2 contributors: mct/npt - updated : 10-01-2016
HGNC name nuclear receptor subfamily 1, group I, member 2
HGNC id 7968
EXPRESSION
Type restricted
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveliver   highly
 stomach    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / hematopoieticbone marrow   
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • a nuclear receptor DNA-binding domain
  • a ligand binding domain (LBD) that uses a novel sequence insert to form a homodimer unique to the nuclear receptor superfamily
  • a AF2 domain necessary for binding with PROX1
  • mono polymer heteromer , dimer
    HOMOLOGY
    interspecies homolog to murine Nr1i2 (77.4pc)
    homolog to rattus Nr1i2 (76.9pc)
    Homologene
    FAMILY
  • nuclear hormone receptor family
  • nuclear receptor superfamily
  • CATEGORY transcription factor , receptor nuclear
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus,nucleoplasm
    text nuclear translocation observed as an essential regulatory event for transcription of its target genes such as CYP3A4
    basic FUNCTION
  • detoxification of cholestatic bile acids
  • regulating the expression of genes involved in the biosynthesis transport and metabolism of bile acids
  • playing a key role in the regulation of both drug metabolism and efflux by inducing the expression of CYP3A4 and MDR1 gene
  • key regulator of genes encoding several major cytochrome P450 enzymes and transporters
  • potential role in breast cancer resistance to drug treatments
  • ligand-activated transcription factor regulating genes central to drug and hormone metabolism in the liver
  • necessary for IL6-mediated repression of the CYP3A4 expression in human hepatocytes
  • transcription factor that induces hepatic drug metabolism by activating cytochrome P450 genes (21127053)
  • may have a function in prediction and treatment of esophageal disease
  • important regulator of xenobiotic metabolism and intestinal integrity
  • co-ordinately up-regulates drug metabolism, transport, and antioxidant genes to protect the vasculature from endogenous and exogenous insults, thus representing a novel gatekeeper for vascular defence
  • CELLULAR PROCESS nucleotide, transcription
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
  • an FGF21-NR1I2 signaling pathway may be involved in decreased hepatic CYP3A4 metabolic activity in Nonalcoholic fatty liver disease (NAFLD)
  • a component
  • heterodimerizing with RXR
  • forms a tryptophan zipper-mediated homodimer, playing a role in the function of this nuclear xenobiotic receptor
  • NR1I2 and RXRA form a heterotetramer unprecedented in the nuclear receptor family of ligand-regulated transcription factors
  • INTERACTION
    DNA binding to a response element in CYP3A4
    RNA
    small molecule
    protein
  • immune-regulatory role in T lymphocytes and SOCS1 is an early signal in NR1I2-mediated T lymphocyte suppression
  • GADD45B is a direct target for NR1I2, eliciting cell signals to regulate various cellular functions
  • eliciting MAPK14 phosphorylation for cell migration
  • NR1I2 promoter methylation is involved in the regulation of intestinal NR1I2 and CYP3A4 mRNA expression and might be associated with the inter-individual variability of the drug responses of colon cancer cells
  • NR1I2 represses SULT1E1, possibly attenuating the inactivation of estrogen
  • PROX1 could negatively regulate NR1I2 signals in some tumor cells, such as hepatocellular carcinoma (HCC) cells, where both NR1I2 and PROX1 are expressed
  • RBCK1 ubiquitinates NR1I2, and this may target NR1I2 for degradation by the ubiquitin-proteasome pathway
  • both ELANE and PRTN3 cleave the human NR1I2 N terminus at sites distinct from the thrombin cleavage site
  • regulates innate immunity via activation of NLRP3 inflammasome in vascular endothelial cells
  • cross-talk between NR1I2 and AHR plays a role in the regulation of CYP3A4 gene expression
  • NR1I2 plays a central role in cortisol-mediated induction of CYP3A4 activity during pregnancy
  • cell & other
    REGULATION
    activated by pregnanes, toxic bile acid, lithocholic acid
    induced by catatoxic steroids
    Other SUMOylated to repress the inflammatory response
    post-translational regulation of NR1I2 via phosphorylation-facilitated ubiquitination by DYRK2 and UBR5
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in adenocarcinoma tissue and columnar Barrett epithelium
    Susceptibility to ulcerative colitis (UC)
    Variant & Polymorphism SNP
  • rs2276707 was weakly associated with UC susceptibility
  • Candidate gene
    Marker
  • prognostic factor in epithelial ovarian cancer and may represent a useful marker to identify patients at risk of recurrence or death
  • Therapy target
    ANIMAL & CELL MODELS
  • Pxr-deficient mice exhibit an exaggerated T lymphocyte proliferation and increased CD25 expression